NCT05801783 2023-04-06A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian CancerShanghai Yunying Medical TechnologyPhase EARLY_PHASE1 Unknown10 enrolled